Rupert Vessey
Förmögenhet: 792 053 $ per 2026-07-31
Förmögenhet: 792 053 $ per 2026-07-31
Rupert J.
Vessey is currently Non-Executive Director at Generate Biomedicines, Inc. since 2024, Director at PharmAkea, Inc., Independent Director at Marengo Therapeutics, Inc. since 2018, Director at Sidecar Therapeutics, Inc., Director at Nereid Therapeutics, Inc. since 2021, Independent Director at Bio-Techne Corp.
since 2019, Chief Scientist & Executive Partner at Flagship Pioneering, LLC since 2023, and Member of The Royal College of Physicians.
Former roles include Director at Juno Therapeutics, Inc. from 2017 to 2018, President-Research & Early Development at Celgene Corp.
from 2015 to 2019, Clinical Development at GlaxoSmithKline, Inc., Executive VP-Research & Early Development at Bristol Myers Squibb Co. from 2019 to 2023, and Senior VP-Early Development & Discovery Sciences at Merck & Co., Inc. Education was completed at the University of Oxford with undergraduate, graduate, and doctorate degrees.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
BIO-TECHNE CORPORATION 0,01 % | 2026-08-11 | 10 987 ( 0,01 % ) | 792 053 $ | 2026-07-31 |
| 2026-02-27 | 0 ( -.--% ) | - $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| BIO-TECHNE CORPORATION | Direktör/Styrelseledamot | 2019-06-26 |
| GENERATE BIOMEDICINES, INC. | Direktör/Styrelseledamot | 2024-06-01 |
PharmAkea, Inc.
PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drug candidates against protein targets involved in fibroproliferative diseases | Direktör/Styrelseledamot | - |
Sidecar Therapeutics, Inc.
Sidecar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direktör/Styrelseledamot | - |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies for cancer treatment | Direktör/Styrelseledamot | 2018-08-01 |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Nereid Therapeutics, Inc.
Nereid Therapeutics, Inc. BiotechnologyHealth Technology Operates as a bio-molecular condensate drug discovery and development company | Direktör/Styrelseledamot | 2021-10-25 |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Privat kapitalinvesterare | 2023-07-01 |
| Företag | Position | Slut |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Teknisk/Vetenskaplig/F&U Direktör | 2023-07-03 |
| ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░ | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 14 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Bio-Techne Corp.
Bio-Techne Corp. BiotechnologyHealth Technology Manufactures and sells biological products | Health Technology |
PharmAkea, Inc.
PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drug candidates against protein targets involved in fibroproliferative diseases | Health Technology |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Sidecar Therapeutics, Inc.
Sidecar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies for cancer treatment | Health Technology |
Nereid Therapeutics, Inc.
Nereid Therapeutics, Inc. BiotechnologyHealth Technology Operates as a bio-molecular condensate drug discovery and development company | Health Technology |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Operates as a clinical-stage generative biology company that provides biotechnology and drug design & development services | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån